TY - JOUR
T1 - Standardization of Epidemiological Surveillance of Group A Streptococcal Impetigo
AU - Strep A Vaccine Global Consortium
AU - Miller, Kate M.
AU - Carapetis, Jonathan R.
AU - Cherian, Thomas
AU - Hay, Roderick
AU - Marks, Michael
AU - Pickering, Janessa
AU - Cannon, Jeffrey W.
AU - Lamagni, Theresa
AU - Romani, Lucia
AU - Moore, Hannah C.
AU - Van Beneden, Chris A.
AU - Barth, Dylan D.
AU - Bowen, Asha C.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A Streptococcus (Strep A) and Staphylococcus aureus, alone or in combination, with the former predominating in many tropical climates. Strep A impetigo occurs mainly in early childhood, and the burden varies worldwide. It is an acute, self-limited disease, but many children experience frequent recurrences that make it a chronic illness in some endemic settings. We present a standardized surveillance protocol including case definitions for impetigo including both active (purulent, crusted) and resolving (flat, dry) phases and discuss the current tests used to detect Strep A among persons with impetigo. Case classifications that can be applied are detailed, including differentiating between incident (new) and prevalent (existing) cases of Strep A impetigo. The type of surveillance methodology depends on the burden of impetigo in the community. Active surveillance and laboratory confirmation is the preferred method for case detection, particularly in endemic settings. Participant eligibility, surveillance population and additional considerations for surveillance of impetigo, including examination of lesions, use of photographs to document lesions, and staff training requirements (including cultural awareness), are addressed. Finally, the core elements of case report forms for impetigo are presented and guidance for recording the course and severity of impetigo provided.
AB - Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A Streptococcus (Strep A) and Staphylococcus aureus, alone or in combination, with the former predominating in many tropical climates. Strep A impetigo occurs mainly in early childhood, and the burden varies worldwide. It is an acute, self-limited disease, but many children experience frequent recurrences that make it a chronic illness in some endemic settings. We present a standardized surveillance protocol including case definitions for impetigo including both active (purulent, crusted) and resolving (flat, dry) phases and discuss the current tests used to detect Strep A among persons with impetigo. Case classifications that can be applied are detailed, including differentiating between incident (new) and prevalent (existing) cases of Strep A impetigo. The type of surveillance methodology depends on the burden of impetigo in the community. Active surveillance and laboratory confirmation is the preferred method for case detection, particularly in endemic settings. Participant eligibility, surveillance population and additional considerations for surveillance of impetigo, including examination of lesions, use of photographs to document lesions, and staff training requirements (including cultural awareness), are addressed. Finally, the core elements of case report forms for impetigo are presented and guidance for recording the course and severity of impetigo provided.
KW - epidemiology
KW - impetigo
KW - infectious disease
KW - Streptococcus pyogenes
KW - surveillance
KW - ACUTE RHEUMATIC-FEVER
KW - ABORIGINAL COMMUNITIES
KW - PYODERMA
KW - SCABIES
KW - BURDEN
UR - http://www.scopus.com/inward/record.url?scp=85159161726&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofac249
DO - 10.1093/ofid/ofac249
M3 - Article
C2 - 36128409
SN - 2328-8957
VL - 9
SP - S15-S24
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - SUPP 1
ER -